Chronic Kidney Disease - PowerPoint PPT Presentation

1 / 53
About This Presentation
Title:

Chronic Kidney Disease

Description:

Chronic Kidney Disease Immunological Compatibility of Donor and Recipient Done to minimize the destruction (rejection) of the transplanted kidney HUMAN LEUKOCYTE ... – PowerPoint PPT presentation

Number of Views:438
Avg rating:3.0/5.0
Slides: 54
Provided by: Marth202
Category:

less

Transcript and Presenter's Notes

Title: Chronic Kidney Disease


1
Chronic Kidney Disease
2
Chronic Kidney Disease
  • Progressive, irreversible damage to the nephrons
    and glomeruli

3
Major causes are
  • Diabetes and high blood pressure
  • Type 1 and type 2 diabetes mellitus
  • High blood pressure (hypertension)
  • Glomerulonephritis
  • Polycystic kidney disease
  • Use of analgesics - acetaminophen(Tylenol)
    and ibuprofen (Motrin, Advil
  • Clogging and hardening of the arteries(atheroscler
    osis) 
  • Obstruction of the flow of urine by stones,
    an enlarged prostate, strictures (narrowings), or
    cancers. 
  • HIV infection, sickle cell disease, heroin abuse,
    amyloidosis, kidney stones, chronic kidney
    infections, and certain cancers.

4
Kidney functions - monitored regularly
  • Diabetes mellitus type 1 or 2 
  • High blood pressure 
  • High cholesterol
  • Heart disease
  • Liver disease 
  • Amyloidosis 
  • Sickle cell disease 
  • Systemic Lupus erythematosus 
  • Vascular diseases such as arteritis, vasculitis,
    or fibromuscular dysplasia 
  • Vesicoureteral reflux (a urinary tract problem in
    which urine travels the wrong way back toward the
    kidney) 
  • Require regular use of anti-inflammatory
    medications 
  • A family history of kidney disease

5
Chronic Renal FailureEnd Stage Renal Disease
(ESRD)
  • Protein and waste metabolism accumulates in the
    blood (azotemia)
  • 90 of kidney function is lost (kidney cannot
    adequately function)
  • Hypothesis Nephrons remains intact, others
    progressively destroyed.
  • Adaptive response maintains function until ¾ are
    destroyed
  • Hypertrophy continues kidneys begin to lose
    their ability to concentrate the urine adequately

6
Table 1. Stages of Chronic Kidney Disease GFR is
glomerular filtration rate, a measure of the
kidney's function.
Stage Description GFRmL/min/1.73m2
1 Slight kidney damage with normal or increased filtration More than 90
2 Mild decrease in kidney function 60-89
3 Moderate decrease in kidney function 30-59
4 Severe decrease in kidney function 15-29
5 Kidney failure Less than 15 (or dialysis)
7
Modifiable Factors -Diabetic Mellitus -Hypertensio
n -Increase Protein and Cholesterol
Intake -Smoking -Use of analgesics
Non-Modifiable Factors -Hereditary -Age greater
than 60 years old -Gender -Race
Decreased renal blood flow Primary kidney
disease Damage from other diseases Urine outflow
obstruction
Chronic Kidney Disease - Pathophysiology
Serum Creatinine
BUN
Decreased glomerular filtration
Hypertrophy of remaining nephrons
Dilute Polyuria
Inability to concentrate urine
Loss of Sodium in Urine
Hyponatremia
Dehydration
Further loss of nephron function
Loss of nonexcretory renal function
2a
Failure to convert inactive forms of calcium
Failure to produce eryhtropoietin
Impaired insulin action
Production of lipids
Immune disturbances
Disturbances in reproduction
Erratic blood glucose levels
Advanced atherosclerosis
Calcium absorption
Anemia Pallor
Delayed wound healing
Infection
Libido
Infertility
1
8
2a
1
Hypocalcemia
Osteodystrophy
Loss of excretory renal function
Excretion of nitrogenous waste
Decreased sodium reabsorption in tubule
Decreased potassium excretion
Decreased phosphate excretion
Decreased hydrogen excretion
Uremia
Hyperkalemia
Hyperphosphatemia
Metabolic acidosis
Water Retention
BUN, Creatinine Uric Acid
Decreased calcium absorption
Hypertension Heart Failure Edema
Proteniuria
Hypocalcemia
Peripheral nerve changes
Hyperparathyroidism
Decreased potassium excretion
Pericarditis
Increased potassium
CNS changes
Pruritus
Altered Taste
Bleeding Tendencies
9
  • Weakness and tiredness/ fatigue.
  • Nocturia is often an early symptom
  • Itchiness of the skin which can progressively
    worsen
  • Pale skin which is easily bruised
  • Muscular twitches, cramps and pain
  • Pins and needles in the hands and feet
  • Nausea

10
As the condition worsens the symptoms progress to
  • Oedema (swelling of the face, limbs and abdomen)
  • Oliguria (greatly reduced volume of urine)
  • Dyspnoea (breathlessness)
  • Vomiting
  • Confusion
  • Seizures
  • Severe lethargy
  • Very itchy skin
  • Breath that smells of ammonia

11
Associated complications of chronic Kidney
Disease would be
  • Anaemia, mostly due to deficiency of
    erythropoietin
  • Bleeding which is caused by impairment of
    platelet function
  • Metabolic Bone Disease (known as Renal
    Osteodystrophy)

12
Associated complications of chronic Kidney
Disease would be
  • Cardiovascular Disease
  • - hypertension, (which may further
    exacerbate
  • the renal failure)
  • -accelerated atherosclerosis
  • -pericarditis. 80 of those with chronic
    renal
  • failure develop hypertension which must
    be
  • treated

13
Associated complications of chronic Kidney
Disease would be
  • Nervous system neuropathy caused by the loss of
    myelin from nerve fibres may improve when
    dialysis is established
  • Gastrointestinal complications - anorexia, nausea
    and vomiting, and a higher incidence of peptic
    ulcer disease

14
Associated complications of chronic Kidney
Disease would be
  • Skin disease itching, which is attributed to
    the retention of metabolic waste products. It
    often improves with dialysis. Dry skin can also
    occur
  • Muscle dysfunction - myopathy leading to muscle
    cramps and the restless leg syndrome

15
Associated complications of chronic Kidney
Disease would be
  • Metabolic dysfunction - involving lipids, insulin
    and uric acid (gout). Metabolic acidosis is also
    associated

16
(No Transcript)
17
Diagnosis
  • Estimated GFR (eGFR)
  • Electrolyte levels and acid-base balance  
  • Blood cell counts 
  • Other tests
  • Ultrasound
  • Biopsy
  • Urine Tests
  • Urinalysis
  • Twenty-four hour urine tests 
  • Glomerular filtration rate (GFR)
  • Blood Tests
  • Creatinine and urea (BUN) in the blood

18
Treatment Modalities
  • Decrease fluid 1000ml/day
  • Decrease protein (.5-1kg body weight)
  • Decrease sodium (1-4gm variable)
  • Decrease potassium
  • Decrease phosphorous (lt1000mg/day)
  • Dialysis (periotoneal, hemodialysis)
  • RBC, Vitamin D (calcitrol replacement) etc.

19
Dialysis Hemodialyis(Hemo)Peritoneal (PD)
  • General Principal Movement of fluid and
    molecules across a semi permeable membrane from
    one compartment to another
  • Hemodialysis Move substances from blood through
    a semi permeable membrane and into a dialysis
    solution (dialysate bath) (synethetic membrane)
  • Peritoneal Peritoneal membrane is the semi
    permeable membrane

20
Osmosis-Diffusion-Ultrafiltration
Osmosis - movement fluid from an area of lt to gt
concentration of solutes (particles)
  • Diffusion - movement of solutes (particles)
    from an area of gt concentration to area of lt
    concentration Remove urea, creatinine, uric
    acid and electrolytes, from the blood to the
    dialystate bath RBC, WBC, Large plasma proteins
    do not go through
  • Ultrafiltration Water and fluid removed when
    the pressure gradient across the membrane is
    created, by increase pressure in the blood
    compartment decrease pressure in the dialysate
    compartment

21
Peritoneal Dialysis
  • Catheter placement anterior abdominal wall
  • Tenckoff (25cm length with cuff anchor and
    migration)
  • Dialysis solution (1-2 liters sometimes smaller)
  • Three phases of PD
  • Inflow (fill) approximately 10 minutes, could
    be in cycles)
  • Dwell (equilibration) (approximately 20-30 min
    or 8 hours)
  • Drain (approximately 15 minutes)
  • These 3 phases are called Exchanges

22
Peritoneal Dialysis
23
Hemodialysis
  • Vascular access for high blood flow
  • Shunts, (teflon, external)
  • Arteriovenous fistulas and grafts (AV)
  • Anastomosis between an artery and vein
  • Fistulas are native vessels (4-6 wks maturity)
  • Grafts are artificial/synthetic material

24
Hemodialysis
AV Fistula Communication
AV Graph Access
25
Hemodialysis
Hemodialysis Machine
Hemodialysis Circuit
26
PD Advantages and Disadvantages
Advantages
Disadvantages
  • Bacterial/chemical peritonitis
  • Protein loss
  • Exit site of catheter
  • Self image
  • Hyperglycemia
  • Surgical placement of catheter
  • Multiple abdominal surgery
  • Immediate initiation
  • Less complicated
  • Portable (CAPD)
  • Fewer dietary restrictions
  • Short training time
  • Less cardio stress
  • Choice for diabetics

27
Hemo Advantages Disadvantages
Advantages
Disadvantages
  • Rapid fluid removal
  • Rapid removal of urea creatinine
  • Effective K removal
  • Less protein loss
  • Lower triglycerides
  • Home dialysis possible
  • Temporary access at the bedside
  • Vascular access problems
  • Dietary fluid restrictions
  • Heparinization
  • Extensive equipment
  • Hypotension
  • Added blood lost
  • Trained specialist

28
Disequalibrium Syndrome
  • Fluid removal and decrease in BUN during
    hemodilaysis which cause changes in blood
    osmolarity.These changes trigger a fluid shift
    from the vascular compartment into the cells. In
    the brain, this can cause cerebral edema,
    resulting in increase intracranial pressure and
    visible signs of decreasing level of
    consciousness. Symptoms Sudden onset of
    headache, nausea and vomiting, nervousness,
    muscle twitching, palpitation, disorientation and
    seizures
  • Treatment Hypertonic saline, Normal saline

29
The following are general dietary guidelines 
  • Protein restriction 
  • Salt restriction
  • Fluid intake 
  • Potassium restriction 
  • Phosphorus restriction 
  • Control blood pressure and/or diabetes 
  • Stop smoking and
  • Lose Excess Weight

30
Avoided or used with caution
  • Certain analgesics Aspirin ibuprofen
  • Fleets or phosphosoda enemas because of their
    high content of phosphorus 
  • Laxatives and antacids containing magnesium and
    aluminum such as magnesium hydroxide
  • Ulcer medication H2-receptor antagonists cimetidi
    ne, ranitidine
  • Decongestants such as pseudoephedrine  especially
    if they have high blood pressure 
  • Herbal medications


31
Nursing Care Pre, Post Dialysis
  • Weigh before after
  • Assess site before after (bruit, thrill,
    infection, bleeding etc.)
  • Medications (precautions before after)
  • Vital signs before and after etc.

32
Renal Transplant
  • Living and Cadaveric donors
  • Predialysis obtain a dry weight free of excess
    fluids and toxins
  • More preparation time from a living donor vs.
    cadaveric transplant within 36 hours of
    procurement
  • Delay may increase ATN
  • Pre-transplant Immunotherapy (IV
    methylprednisolone sodium succinate, (A
    methaPred, Solu-Medrol), cyclosporine
    (Sandimmune and azathioprine ((Imuran)

33
Complications Post Transplant
  • Rejection is a major problem
  • Hyperacute rejection occurs within minutes to
    hours after transplantation
  • Renal vessels thrombosis occurs and the kidney
    dies
  • There is no treatment and the transplanted kidney
    is removed

34
Immunological Compatibility of Donor and
Recipient
  • Done to minimize the destruction (rejection) of
    the transplanted kidney
  • HUMAN LEUKOCYTE ANTIGEN (HLA)
  • This gives you your genetic identity (twins share
    identical HLA)
  • HLA compatibility minimizes the recognition of
    the transplanted kidney as foreign tissues.

35
Immunological Analysis
  • WHITE CELL CROSS MATCH (the recipient serum is
    mixed with donor lymphocytes to test for
    performed cytotoxic (anti-HLA) antibodies to the
    potential donor kidney
  • A positive cross match indicates that the
    recipient has cytotoxic antibodies to the donor
    and is an absolute contraindication to
    transplantation

36
Immulogical Analysis
  • MIXED LYMPHOCYTE CULTURE
  • The donor and recipient lymphocytes are
  • mixed. Result HIGH SENTIVITY, this is
    contraindicated for renal transplantation.
  • ABO BLOOD GROUPING
  • ABO blood group must be compatible

37
Surgery
  • LLQ of the abdomen outside of the peritoneal
    cavity
  • Renal artery and vein anastomosed to the
    corresponding iliac vessels
  • Donor ureters are tunneled into the recipients
    bladder.

38
Complications Post Transplant
  • Acute Rejection occurs 4 days to 4 months after
    transplantation
  • It is not uncommon to have at least one rejection
    episode
  • Episodes are usually reversible with additional
    immunosuppressive therapy (Corticosteroids,
    muromonab-CD3, ALG, or ATG)
  • Signs increasing serum creatinine, elevated BUN,
    fever, wt. gain, decrease output, increasing BP,
    tenderness over the transplanted kidneys

39
Complications Post Transplant
  • Chronic Rejection occurs over months or years
    and is irreversible.
  • The kidney is infiltrated with large numbers of T
    and B cells characteristic of an ongoing , low
    grade immunological mediated injury
  • Gradual occlusion renal blood vessels
  • Signs proteinuria, HTN, increase serum
    creatinine levels
  • Supportive treatment, difficult to manage
  • Replace on transplant list

40
Complications Post Transplant
  • Infection
  • Hypertension
  • Malignancies (lip, skin, lymphomas, cervical)
  • Recurrence of renal disease
  • Retroperiotneal bleed
  • Arterial stenosis
  • Urine leakage

41
100 patients with eGFR lt 60 (Tuesday morning in
Outpatients)
42
Tuesday morning 1 year later 1 patient needs
RRT, 10 patients have died (gt 50 CV death)
43
Tuesday morning 10 years later 8 patients need
RRT, 65 patients have died, 27 have ongoing CKD
44
  • The majority of patients with CKD 1-3 do not
    progress to ESRF.
  • Their risk of cardiovascular death is higher
    than their risk of progression.

45
Optimise risk factors
  • Cardiovascular disease
  • Proteinuria
  • Hypertension
  • Diabetes
  • Smoking
  • Obesity
  • Exercise tolerance

TAKE HOME MESSAGE
46
Nursing Care Plan of a Patient With ESRD
  • Nursing diagnosis Excess fluid volume related
    to decreased urine output, dietary excesses, and
    retention of sodium and water.
  • Goal Maintenance of ideal body weight without
    excess fluid.

47
  • Assess fluid status (Daily weight, intake and
    output balance, skin turgor and presence of
    edema, distention of neck veins, blood pressure,
    pulse rate, and rhythm, respiratory rate and
    effort).
  • Limit fluid intake to prescribed volume.
  • Identify potential sources of fluid (medications
    and fluids used

    to take
    medications oral and intravenous, foods).
  • Explain to patient and family rationale for
    restriction.

48
Nursing Care Plan of a Patient With ESRD (Cont)
  • Nursing diagnosis Imbalanced nutrition less
    than body requirements related to anorexia,
    nausea, vomiting, and dietary restrictions.
  • Goal Maintenance of adequate nutritional
    intake.

49
  • Interventions The nurse should
  • Assess nutritional status (weight changes, serum
    electrolyte, BUN, creatinine, protein,
    transferrin, and iron levels).
  • Assess patients nutritional dietary patterns
    (diet history, food preferences, calorie counts).
  • Assess for factors contributing to altered
    nutritional intake (Anorexia, nausea, or
    vomiting, diet unpalatable to patient,
    depression, lack of understanding of dietary
    restrictions, stomatitis).
  • Provide patients food preferences within
    dietary restrictions.
  • Promote intake of high biologic value protein
    foods

50
Nursing Care Plan of a Patient With ESRD (Cont)
  • Nursing diagnosis Deficient knowledge regarding
    condition and treatment.
  • Goal Increased knowledge about condition and
    related treatment.

51
  • Interventions The nurse should
  • Assess understanding of cause of renal failure,
    its meaning and consequences, and its treatment.
  • Provide explanation of renal function and
    consequences of renal failure at patients level
    of understanding and guided by patients
    readiness to learn.
  • Provide oral and written information as
    appropriate about renal function and failure,
    fluid and dietary restrictions, medications,
    reportable problems, signs, and symptoms,
    follow-up schedule, community resources, and
    treatment options.

52
Nursing Care Plan of a Patient With ESRD (Cont)
  • Nursing diagnosis Activity intolerance related
    to fatigue, anemia, retention of waste products,
    and dialysis procedure.
  • Goal Participation in activity within
    tolerance.
  • Interventions The nurse should
  • Assess factors contributing to fatigue (anemia,
    fluid and electrolyte imbalances, retention of
    waste products, depression)
  • Promote independence in self-care activities as
    tolerated assist if fatigued.
  • Encourage alternating activity with rest.
  • Encourage patient to rest after dialysis
    treatments.

TAKE HOME MESSAGE
53
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com